ApprovalTrail

Approval · Notice of Compliance 25224 · 2021

LINCOMYCIN 110 G: Notice of Compliance 25224

Issued February 17, 2021

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
25224
Date
February 17, 2021
Company
Bio Agri Mix LpMitchell, Ontario, Canada
Product type
Veterinary
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Addition of manufacturing site

Products in this notice

BrandDINStatus today
LINCOMYCIN 110 G02089882Marketed

Medicinal ingredients